Bcr-Abl tyrosine kinase inhibitors- current status
2013 · Infectious Agents and Cancer · 27 citations
https://doi.org/10.1186/1750-9378-8-23
A
Agha Muhammad Hammad Khan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
47
Papers
375
Citations
7
h-index
7
i10-index
Agha Muhammad Hammad Khan is an academic researcher. The author has contributed to research in topics: Advanced Radiotherapy Techniques & Radiomics and Machine Learning in Medical Imaging & Advances in Oncology and Radiotherapy. The author has an h-index of 7, co-authored 40 publications.
ORCID: 0000-0002-4160-5618Papers by this author
worksc-Met inhibitors
2013 · Infectious Agents and Cancer · 25 citations
https://doi.org/10.1186/1750-9378-8-13
Implementation of a student-run initiative to facilitate multidisciplinary cancer care in Pakistan: the Tumor Board Establishment Facilitation Forum
2025 · BMC Medical Education · 1 citations
https://doi.org/10.1186/s12909-025-06761-3
Adjuvant radiotherapy for endometrial cancer in a renal transplant patient - a case report
2021 · European Journal of Medical Case Reports · 0 citations
https://doi.org/10.24911/ejmcr/173-1615803452
In Regard to Hesse et al
2022 · Advances in Radiation Oncology · 0 citations
https://doi.org/10.1016/j.adro.2022.100963
3466 Outcomes following Stereotactic Radiotherapy to the Pelvis in the Oligometastatic setting having previously had Prostate Cancer Radiotherapy
2025 · Radiotherapy and Oncology · 0 citations
https://doi.org/10.1016/s0167-8140(25)01734-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat